Lasa Supergenerics Ltd Q2 FY22 Share Price & Earnings Call Analysis

Financials of Lasa Supergenerics Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Lasa Supergenerics Ltd

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +31.7035.3230.5624.3026.6622.8230.8439.3933.0839.1420.013.062.20
Expenses +34.1630.9826.5123.2525.6026.8129.0438.6032.8135.7320.517.062.95
Operating Profit-2.464.344.051.051.06-3.991.800.790.273.41-0.50-4.00-0.75
OPM %-7.76%12.29%13.25%4.32%3.98%-17.48%5.84%2.01%0.82%8.71%-2.50%-130.72%-34.09%
Other Income +0.86-18.970.000.080.00-8.760.001.958.91-21.52-20.440.010.02
Interest0.430.410.370.560.440.560.871.240.470.110.030.120.11
Depreciation3.094.172.652.682.682.662.792.812.803.901.571.571.57
Profit before tax-5.12-19.211.03-2.11-2.06-15.97-1.86-1.315.91-22.12-22.54-5.68-2.41
Tax %-3.91%-21.92%580.58%-99.05%-29.61%-4.20%46.77%146.56%7.11%-35.40%-6.30%10.04%5.81%
Net Profit +-4.92-15.00-4.95-0.02-1.46-15.30-2.73-3.235.49-14.29-21.12-6.25-2.55
EPS in Rs-1.21-2.99-0.99-0.00-0.29-3.05-0.54-0.641.10-2.85-4.22-1.25-0.51

Financials of Lasa Supergenerics Ltd

Profit & Loss

Annual income statement trend

Mar 2016 1mMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +019924417016720113713010414264
Expenses +015320215813715412013610213666
Operating Profit0464111304716-626-2
OPM %23%17%7%18%24%12%-5%2%4%-3%
Other Income +0-243000-8-18-9-11-42
Interest0121188204230
Depreciation0818191716151311129
Profit before tax0215-16530-6-42-19-19-53
Tax %-10%19%-25%23%23%-13%-9%14%-24%
Net Profit +0212-12423-5-39-22-15-44
EPS in Rs5.40-5.260.895.60-1.31-7.71-4.34-2.95-8.83
Dividend Payout %0%0%0%0%4%-24%0%0%0%

Financials of Lasa Supergenerics Ltd

Balance Sheet

Capital structure and asset base

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital0.050.05232341415050505050
Reserves07594821011181086847346
Borrowings +011610785481920222227
Other Liabilities +03763694229312432168
Total Liabilities022828725823220820916415110272
Fixed Assets +01191701621521431371191106858
CWIP030770055300
Investments00000000000
Other Assets +0801109080656740393313
Total Assets022828725823220820916415110272

Financials of Lasa Supergenerics Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +0-3404114419-172-3
Cash from Investing Activity +00-44-7-2-4-311-08
Cash from Financing Activity +004-33-10-36-0-4-2-6
Net Cash Flow0-30-0216-10-0-0
Free Cash Flow0-5-629133512-1205
CFO/OP-6%103%397%46%87%73%273%96%-45%

Financials of Lasa Supergenerics Ltd

Ratios

Working capital efficiency and return ratios

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days6463624527507134
Inventory Days9390901015646489284
Days Payable711021701304168326835
Cash Conversion Cycle8751-18164228223753
Working Capital Days15-1-52-133512-17-4437
ROCE %42%13%-4%7%17%1%-12%-6%-1%